Established from the tumor tissue removed from the metastatic central nervous system lesion of a 69-year-old man with prostate carcinoma in 1975.
Tumorigenecity:forms adenocarcinoma, grade II consistent with prostatic primary
Isoenzyme:Me-2, 1-2; PGM3, 2; PGM1, 1; ES D, 1; AK1, 1; G6PD, B; GLO-1,2
Histopathology:carcinoma, metastasis to brain
Reverse transcritase:Production